← Evidence map

ArticleOncotarget2017

MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.

Giuseppina Roscigno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

45 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28061479